People

Ian Tomlinson

Ian Tomlinson is an antibody-engineering entrepreneur and founding Start Codon investor, appointed chairman in its2019 primary launch announcement. His statutory director appointment ended11December2023 after starting15April2019. The current owner biography describes former Domantis cofounder/CSO work and GSK business-development leadership. This identity is separate from the similarly named Oxford cancer-genetics professor.